Landscapes / Companies

Shandong New Time Pharmaceutical Co., LTD not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 in Phase 3
2 in Phase 2
Next date
AC591, Phase 2 trial completes
Drugs
11
in active trials · 17 in all
Trials
14 active
26 since 2021

Drugs11

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Phase 2/3 30 Dec 2027Phase 2/3 trial completes
Angiotensin 2 receptor blocker
Phase 3 Dec 2027Phase 3 trial completes
F182112not checked
—
Phase 3 20 May 2028Phase 2 trial completes
—
Phase 3 1 Aug 2028Phase 3 trial completes
Histamine-1 receptor antagonist
Phase 3 —
—
Phase 2 Dec 2026Phase 2 trial completes
—
Phase 2 Feb 2027Phase 2 trial completes
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 Jun 2028Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About

No active trial
6 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Shandong New Time Pharmaceutical Co., LTD

Following is part of Solo: you see every change to Shandong New Time Pharmaceutical Co., LTD the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in